A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)

NCT05768386 · clinicaltrials.gov ↗
ENROLLING_BY_INVITATION
Status
172
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

BioMarin Pharmaceutical